Sagimet Biosciences Inc.
SGMT
$5.14
-$0.07-1.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -12.45% | -1.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -24.90% | 20.20% | |||
| Operating Income | 24.90% | -20.20% | |||
| Income Before Tax | 25.88% | -24.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.88% | -24.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.88% | -24.28% | |||
| EBIT | 24.90% | -20.20% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 26.01% | -23.25% | |||
| Normalized Basic EPS | 26.00% | -23.26% | |||
| EPS Diluted | 26.01% | -23.25% | |||
| Normalized Diluted EPS | 26.00% | -23.26% | |||
| Average Basic Shares Outstanding | 0.17% | 0.84% | |||
| Average Diluted Shares Outstanding | 0.17% | 0.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||